678 related articles for article (PubMed ID: 19369364)
1. The role of the TRPV1 endogenous agonist N-Oleoyldopamine in modulation of nociceptive signaling at the spinal cord level.
Spicarova D; Palecek J
J Neurophysiol; 2009 Jul; 102(1):234-43. PubMed ID: 19369364
[TBL] [Abstract][Full Text] [Related]
2. Tumor necrosis factor alpha sensitizes spinal cord TRPV1 receptors to the endogenous agonist N-oleoyldopamine.
Spicarova D; Palecek J
J Neuroinflammation; 2010 Aug; 7():49. PubMed ID: 20796308
[TBL] [Abstract][Full Text] [Related]
3. TRPV1 receptor inhibition decreases CCL2-induced hyperalgesia.
Spicarova D; Adamek P; Kalynovska N; Mrozkova P; Palecek J
Neuropharmacology; 2014 Jun; 81():75-84. PubMed ID: 24495396
[TBL] [Abstract][Full Text] [Related]
4. Transient receptor potential vanilloid type 1 receptor regulates glutamatergic synaptic inputs to the spinothalamic tract neurons of the spinal cord deep dorsal horn.
Kim H; Cui L; Kim J; Kim SJ
Neuroscience; 2009 May; 160(2):508-16. PubMed ID: 19236908
[TBL] [Abstract][Full Text] [Related]
5. Hypersensitivity Induced by Activation of Spinal Cord PAR2 Receptors Is Partially Mediated by TRPV1 Receptors.
Mrozkova P; Spicarova D; Palecek J
PLoS One; 2016; 11(10):e0163991. PubMed ID: 27755539
[TBL] [Abstract][Full Text] [Related]
6. TRPV1 antagonist, SB-366791, inhibits glutamatergic synaptic transmission in rat spinal dorsal horn following peripheral inflammation.
Lappin SC; Randall AD; Gunthorpe MJ; Morisset V
Eur J Pharmacol; 2006 Jul; 540(1-3):73-81. PubMed ID: 16737693
[TBL] [Abstract][Full Text] [Related]
7. (R)-(5-tert-butyl-2,3-dihydro-1H-inden-1-yl)-3-(1H-indazol-4-yl)-urea (ABT-102) blocks polymodal activation of transient receptor potential vanilloid 1 receptors in vitro and heat-evoked firing of spinal dorsal horn neurons in vivo.
Surowy CS; Neelands TR; Bianchi BR; McGaraughty S; El Kouhen R; Han P; Chu KL; McDonald HA; Vos M; Niforatos W; Bayburt EK; Gomtsyan A; Lee CH; Honore P; Sullivan JP; Jarvis MF; Faltynek CR
J Pharmacol Exp Ther; 2008 Sep; 326(3):879-88. PubMed ID: 18515644
[TBL] [Abstract][Full Text] [Related]
8. Signaling mechanisms of down-regulation of voltage-activated Ca2+ channels by transient receptor potential vanilloid type 1 stimulation with olvanil in primary sensory neurons.
Wu ZZ; Chen SR; Pan HL
Neuroscience; 2006 Aug; 141(1):407-19. PubMed ID: 16678970
[TBL] [Abstract][Full Text] [Related]
9. Potentiation of glutamatergic synaptic transmission by protein kinase C-mediated sensitization of TRPV1 at the first sensory synapse.
Sikand P; Premkumar LS
J Physiol; 2007 Jun; 581(Pt 2):631-47. PubMed ID: 17363391
[TBL] [Abstract][Full Text] [Related]
10. Vanilloid receptor-1 (TRPV1)-dependent activation of inhibitory neurotransmission in spinal substantia gelatinosa neurons of mouse.
Ferrini F; Salio C; Vergnano AM; Merighi A
Pain; 2007 May; 129(1-2):195-209. PubMed ID: 17317009
[TBL] [Abstract][Full Text] [Related]
11. Loss of TRPV1-expressing sensory neurons reduces spinal mu opioid receptors but paradoxically potentiates opioid analgesia.
Chen SR; Pan HL
J Neurophysiol; 2006 May; 95(5):3086-96. PubMed ID: 16467418
[TBL] [Abstract][Full Text] [Related]
12. Sustained inhibition of neurotransmitter release from nontransient receptor potential vanilloid type 1-expressing primary afferents by mu-opioid receptor activation-enkephalin in the spinal cord.
Zhou HY; Chen SR; Chen H; Pan HL
J Pharmacol Exp Ther; 2008 Nov; 327(2):375-82. PubMed ID: 18669865
[TBL] [Abstract][Full Text] [Related]
13. Proteinase-activated receptor-4 (PAR4) activation leads to sensitization of rat joint primary afferents via a bradykinin B2 receptor-dependent mechanism.
Russell FA; Veldhoen VE; Tchitchkan D; McDougall JJ
J Neurophysiol; 2010 Jan; 103(1):155-63. PubMed ID: 19889854
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of peripheral vanilloid TRPV1 receptors reduces noxious heat-evoked responses of dorsal horn neurons in naïve, carrageenan-inflamed and neuropathic rats.
Jhaveri MD; Elmes SJ; Kendall DA; Chapman V
Eur J Neurosci; 2005 Jul; 22(2):361-70. PubMed ID: 16045489
[TBL] [Abstract][Full Text] [Related]
15. Mu-opioid receptor activation modulates transient receptor potential vanilloid 1 (TRPV1) currents in sensory neurons in a model of inflammatory pain.
Endres-Becker J; Heppenstall PA; Mousa SA; Labuz D; Oksche A; Schäfer M; Stein C; Zöllner C
Mol Pharmacol; 2007 Jan; 71(1):12-8. PubMed ID: 17005903
[TBL] [Abstract][Full Text] [Related]
16. Characterization of A-425619 at native TRPV1 receptors: a comparison between dorsal root ganglia and trigeminal ganglia.
McDonald HA; Neelands TR; Kort M; Han P; Vos MH; Faltynek CR; Moreland RB; Puttfarcken PS
Eur J Pharmacol; 2008 Oct; 596(1-3):62-9. PubMed ID: 18755179
[TBL] [Abstract][Full Text] [Related]
17. Direct evidence for activation and desensitization of the capsaicin receptor by N-oleoyldopamine on TRPV1-transfected cell, line in gene deleted mice and in the rat.
Szolcsányi J; Sándor Z; Petho G; Varga A; Bölcskei K; Almási R; Riedl Z; Hajos G; Czéh G
Neurosci Lett; 2004 May; 361(1-3):155-8. PubMed ID: 15135917
[TBL] [Abstract][Full Text] [Related]
18. Modulation of spinal cord synaptic activity by tumor necrosis factor α in a model of peripheral neuropathy.
Spicarova D; Nerandzic V; Palecek J
J Neuroinflammation; 2011 Dec; 8():177. PubMed ID: 22189061
[TBL] [Abstract][Full Text] [Related]
19. TRPV1 receptor mediates glutamatergic synaptic input to dorsolateral periaqueductal gray (dl-PAG) neurons.
Xing J; Li J
J Neurophysiol; 2007 Jan; 97(1):503-11. PubMed ID: 17065246
[TBL] [Abstract][Full Text] [Related]
20. The Cancer Chemotherapeutic Paclitaxel Increases Human and Rodent Sensory Neuron Responses to TRPV1 by Activation of TLR4.
Li Y; Adamek P; Zhang H; Tatsui CE; Rhines LD; Mrozkova P; Li Q; Kosturakis AK; Cassidy RM; Harrison DS; Cata JP; Sapire K; Zhang H; Kennamer-Chapman RM; Jawad AB; Ghetti A; Yan J; Palecek J; Dougherty PM
J Neurosci; 2015 Sep; 35(39):13487-500. PubMed ID: 26424893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
